Increasing bioavailability of silymarin using a buccal liposomal delivery system: Preparation and experimental design investigation

被引:181
作者
El-Samaligy, MS [1 ]
Afifi, NN [1 ]
Mahmoud, EA [1 ]
机构
[1] Cairo Univ, Fac Pharm, Dept Pharmaceut, Cairo, Egypt
关键词
liposomes; silymarin; hybrid liposomes; transmucosal delivery system; experimental factorial design; bioavailability;
D O I
10.1016/j.ijpharm.2005.11.006
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Silymarin is a natural lipotropic agent of low bioavailability from oral products. The aim of our study is to prepare buccal liposomal delivery system of silymarin with higher bioavailability. The effect of lecithin: cholesterol molar ratio on the percentage drug encapsulated was investigated. The influence of fluctuating the amount of added drug was also determined. The effect of additives such as positive charge inducer, negative charge inducer and surfactants was studied using two different 23 full factorial designs. Furthermore, additives used to optimize liposomal product were also investigated for their optimal concentrations, release properties and in vitro permeation and absorption through chicken cheek pouch. Optimal liposomal encapsulation efficiency was found at 7:4 lecithin to cholesterol molar ratio. A decrease in entrapment efficiency with increasing cholesterol content was observed. Tween 20 or Tween 80 beyond 0.5 molar ratio decreased the entrapment efficiency. Positively charged liposomes showed superior entrapment efficiency over neutral and negatively charged liposomes. Release studies as well as permeation and absorption studies showed that hybrid liposomes prepared according to formula 3 containing lecithin, cholesterol, stearyl amine and Tween 20 in 9:1:1:0.5 molar ratio, respectively, gave the best drug absorption and permeation. It showed steady state permeation through chicken cheek pouch for 6h. This is expected to improve the bioavailability of silymarin in the developed liposomal buccal delivery system, as the results show an increase in drug penetration compared to free drug powder. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:140 / 148
页数:9
相关论文
共 43 条
[1]
Further aspects on the hemolytic activity of the antibiotic lipopeptide iturin A [J].
Aranda, FJ ;
Teruel, JA ;
Ortiz, A .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2005, 1713 (01) :51-56
[2]
LIPOSOMAL ENCAPSULATION AND STABILITY OF DIDEOXYINOSINE TRIPHOSPHATE [J].
BETAGERI, GV .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1993, 19 (05) :531-539
[3]
BLUMENTHAL M, 2000, HERBAL MED INTEGRATI
[4]
Preparation and evaluation of a chitosan salt-poloxamer 407 based matrix for buccal drug delivery [J].
Cafaggi, S ;
Leardi, R ;
Parodi, B ;
Caviglioli, G ;
Russo, E ;
Bignardi, G .
JOURNAL OF CONTROLLED RELEASE, 2005, 102 (01) :159-169
[5]
Dissolution test for silymarin tablets and capsules [J].
Campodónico, A ;
Collado, E ;
Ricci, R ;
Pappa, H ;
Segall, A ;
Pizzorno, MT .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2001, 27 (03) :261-265
[6]
Preparation and properties of new unilamellar non-ionic/ionic surfactant vesicles [J].
Carafa, M ;
Santucci, E ;
Alhaique, F ;
Coviello, T ;
Murtas, E ;
Riccieri, FM ;
Lucania, G ;
Torrisi, MR .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 160 (01) :51-59
[7]
Oral particulate delivery: status and future trends [J].
Chen, HM ;
Langer, R .
ADVANCED DRUG DELIVERY REVIEWS, 1998, 34 (2-3) :339-350
[8]
LIPOSOMES AS A CARRIER FOR ORAL-ADMINISTRATION OF INSULIN - EFFECT OF FORMULATION FACTORS [J].
CHOUDHARI, KB ;
LABHASETWAR, V ;
DORLE, AK .
JOURNAL OF MICROENCAPSULATION, 1994, 11 (03) :319-325
[9]
Permeability investigations of phospholipid liposomes by adding cholesterol [J].
Cócera, M ;
López, O ;
Coderch, L ;
Parra, JL ;
de la Maza, A .
COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS, 2003, 221 (1-3) :9-17
[10]
SCAVENGING EFFECT OF SILIPIDE, A NEW SILYBIN-PHOSPHOLIPID COMPLEX, ON ETHANOL-DERIVED FREE-RADICALS [J].
COMOGLIO, A ;
TOMASI, A ;
MALANDRINO, S ;
POLI, G ;
ALBANO, E .
BIOCHEMICAL PHARMACOLOGY, 1995, 50 (08) :1313-1316